Commentary

Video

DIssecting the Current Treatment Landscape for R/R Follicular Lymphoma

Author(s):

Grzegorz S. Nowakowski, MD,Samuel Yamshon, MD

Grzegorz S. Nowakowski, MD, and Samuel Yamshon, MD, break down the current treatment landscape for relapsed/refractory follicular lymphoma.

Related Videos
Javier Pinilla, MD, PhD, and Talha Badar, MBBS, MD, discuss factors that influence later-line treatment choices in chronic myeloid leukemia.
Javier Pinilla, MD, PhD, and Talha Badar, MBBS, MD, on the implications of the FDA approval of asciminib in newly diagnosed CP-CML.
Dasom (Caroline) Lee, MD
Nosha Farhadfar, MD, and Chandler Park, MD, FACP
Shaji Kumar, MD
Shaji Kumar, MD
Alex Herrera, MD
Grzegorz S. Nowakowski, MD, consultant, Division of Hematology, Department of Internal Medicine, enterprise deputy director, Clinical Research, professor, oncology, medicine, Mayo Clinic Comprehensive Cancer Center
Grzegorz S. Nowakowski, MD
Francisco Hernandez-Ilizaliturri, MD, professor, oncology, Department of Medicine—Lymphoma; director, Lymphoma Research, head, Lymphoma Translational Research Lab; associate professor, Department of Immunology, Roswell Park Comprehensive Cancer Center; clinical professor, Department of Medicine, Jacobs School of Medicine and Biomedical Sciences, University at Buffalo
Related Content
S. Vincent Rajkumar, MD
December 17th 2024

Research Shows New Treatment Could Delay Cancer Progression in Patients With High-Risk Smoldering Multiple Myeloma

Stephen Liu, MD; Sara A. Hurvitz, MD, FACP; S. Vincent Rajkumar, MD; Sumanta Kumar Pal, MD, FASCO; Shubham Pant, MD, MBBS
May 23rd 2024

Oncology Experts Preview Top Abstracts From the 2024 ASCO Annual Meeting

Fixed-Duration Epcoritamab Is Active, Safe in Older Newly Diagnosed LBCL
December 10th 2024

Fixed-Duration Epcoritamab Is Active, Safe in Older Newly Diagnosed LBCL

Matthew Lunning, DO, FACP
December 21st 2023

Lunning and Mehta-Shah Unpack Treatment Needs and Future Directions in PTCL

Follicular Lymphoma
December 9th 2024

Tisagenlecleucel Maintains Long-Term Efficacy in R/R Follicular Lymphoma

Diffuse Large B-cell Lymphoma | Image Credit: © Свет Лана – stock.adobe.com
December 8th 2024

US Real-World Analysis Supports Clinical Benefit of Tafasitamab in R/R DLBCL